798 related articles for article (PubMed ID: 22500372)
1. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis].
Zlatanović G; Jovanović S; Veselinović D; Zivković M
Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372
[TBL] [Abstract][Full Text] [Related]
2. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.
Calvo-Río V; Blanco R; Beltrán E; Sánchez-Bursón J; Mesquida M; Adán A; Hernandez MV; Hernandez Garfella M; Valls Pascual E; Martínez-Costa L; Sellas-Fernández A; Cordero Coma M; Díaz-Llopis M; Gallego R; Salom D; García Serrano JL; Ortego N; Herreras JM; Fonollosa A; García-Aparicio AM; Maíz O; Blanco A; Torre I; Fernández-Espartero C; Jovani V; Peiteado-Lopez D; Pato E; Cruz J; Fernández-Cid C; Aurrecoechea E; García M; Caracuel MA; Montilla C; Atanes A; Hernandez FF; Insua S; González-Suárez S; Sánchez-Andrade A; Gamero F; Linares L; Romero-Bueno F; García AJ; Almodovar R; Minguez E; Carrasco Cubero C; Olive A; Vázquez J; Ruiz Moreno O; Jiménez-Zorzo F; Manero J; Muñoz Fernández S; Rueda-Gotor J; González-Gay MA
Rheumatology (Oxford); 2014 Dec; 53(12):2223-31. PubMed ID: 24996907
[TBL] [Abstract][Full Text] [Related]
3. Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.
Accorinti M; Pirraglia MP; Paroli MP; Priori R; Conti F; Pivetti-Pezzi P
Jpn J Ophthalmol; 2007; 51(3):191-6. PubMed ID: 17554481
[TBL] [Abstract][Full Text] [Related]
4. [Ocular manifestations in Behçet's disease].
Desbois AC; Terrada C; Cacoub P; Bodaghi B; Saadoun D
Rev Med Interne; 2018 Sep; 39(9):738-745. PubMed ID: 29625716
[TBL] [Abstract][Full Text] [Related]
5. Use of ultrasound biomicroscopy, indocyanine green angiography and HLA-B51 testing as adjunct methods in the appraisal of Behçet's uveitis.
Klaeger AJ; Tran VT; Hiroz CA; Morisod L; Herbort CP
Int Ophthalmol; 2004 Jan; 25(1):57-63. PubMed ID: 15085978
[TBL] [Abstract][Full Text] [Related]
6. Eye and Behçet's disease.
Ksiaa I; Abroug N; Kechida M; Zina S; Jelliti B; Khochtali S; Attia S; Khairallah M
J Fr Ophtalmol; 2019 Apr; 42(4):e133-e146. PubMed ID: 30850197
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience.
Sota J; Cantarini L; Vitale A; Sgheri A; Gentileschi S; Caggiano V; Gelardi V; Frediani B; Tosi GM; Fabiani C
Mediators Inflamm; 2020; 2020():6872402. PubMed ID: 32508524
[TBL] [Abstract][Full Text] [Related]
8. [Clinical features of patients with Behcet's uveitis].
Liu XS; Gao F; Zhao C; Zhang MF
Zhonghua Yan Ke Za Zhi; 2020 Mar; 56(3):217-223. PubMed ID: 32187951
[No Abstract] [Full Text] [Related]
9. Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients.
Barroso-García N; Atienza-Mateo B; Ferraz-Amaro I; Prieto-Peña D; Beltrán E; Adán A; Hernández-Garfella M; Martínez-Costa L; Cordero-Coma M; Díaz-Llopis M; Herreras JM; Maíz-Alonso O; Torre-Salaberri I; De Vicente-Delmás A; Díaz-Valle D; Atanes-Sandoval A; Francisco F; Insua S; Sánchez J; Almodóvar-González R; Jiménez-Sosa A; Ruiz-Moreno O; Gandía-Martínez M; Nolla JM; Calvo-Río V; Castañeda S; González-Gay MA; Blanco R
Semin Arthritis Rheum; 2023 Feb; 58():152153. PubMed ID: 36549244
[TBL] [Abstract][Full Text] [Related]
10. Improvement of neurological and ocular symptoms of Behçet's disease after the introduction of infliximab.
Barešić M; Reihl M; Habek M; Vukojević N; Anić B
Rheumatol Int; 2018 Jul; 38(7):1301-1306. PubMed ID: 29777341
[TBL] [Abstract][Full Text] [Related]
11. Pattern of uveitis in Behçet's disease in a referral center in Tunisia, North Africa.
Khairallah M; Attia S; Yahia SB; Jenzeri S; Ghrissi R; Jelliti B; Zaouali S; Messaoud R
Int Ophthalmol; 2009 Jun; 29(3):135-41. PubMed ID: 18365145
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of adalimumab versus conventional therapy in sight-threatening refractory Behçet's uveitis with vasculitis.
Yang S; Huang Z; Liu X; Li H; Xie L; Chen X; Wen F; Liang D; Su W
Int Immunopharmacol; 2021 Apr; 93():107430. PubMed ID: 33581500
[TBL] [Abstract][Full Text] [Related]
13. Pattern and causes of visual loss in Behçet's uveitis: short-term and long-term outcomes.
Amer R; Alsughayyar W; Almeida D
Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1423-1432. PubMed ID: 28396946
[TBL] [Abstract][Full Text] [Related]
14. Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease.
Park JY; Chung YR; Lee K; Song JH; Lee ES
Yonsei Med J; 2015 Jul; 56(4):1158-62. PubMed ID: 26069144
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of Behçet's disease in the Indian population.
Sachdev N; Kapali N; Singh R; Gupta V; Gupta A
Int Ophthalmol; 2009 Dec; 29(6):495-501. PubMed ID: 18936879
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate in ocular manifestations of Behcet's disease: a longitudinal study up to 15 years.
Davatchi F; Shams H; Shahram F; Nadji A; Chams-Davatchi C; Sadeghi Abdollahi B; Faezi T; Akhlaghi M; Ashofteh F
Int J Rheum Dis; 2013 Oct; 16(5):568-77. PubMed ID: 24164845
[TBL] [Abstract][Full Text] [Related]
17. Ocular Manifestations and Visual Outcomes of Behçet's Uveitis in a Thai population.
Pathanapitoon K; Kunavisarut P; Saravuttikul FA; Rothova A
Ocul Immunol Inflamm; 2019; 27(1):2-6. PubMed ID: 29020486
[TBL] [Abstract][Full Text] [Related]
18. Infliximab in refractory uveitis due to Behçet's disease.
Wechsler B; Sablé-Fourtassou R; Bodaghi B; Huong DL; Cassoux N; Badelon I; Fain O; LeHoang P; Piette JC
Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S14-6. PubMed ID: 15515776
[TBL] [Abstract][Full Text] [Related]
19. [Eye and Behçet's disease].
Ksiaa I; Abroug N; Kechida M; Zina S; Jelliti B; Khochtali S; Attia S; Khairallah M
J Fr Ophtalmol; 2019 Jun; 42(6):626-641. PubMed ID: 31164292
[TBL] [Abstract][Full Text] [Related]
20. Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.
Kötter I; Zierhut M; Eckstein AK; Vonthein R; Ness T; Günaydin I; Grimbacher B; Blaschke S; Meyer-Riemann W; Peter HH; Stübiger N
Br J Ophthalmol; 2003 Apr; 87(4):423-31. PubMed ID: 12642304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]